These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33066813)

  • 1. Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer.
    Wang H; Chong T; Li BY; Chen XS; Zhen WB
    Biol Res; 2020 Oct; 53(1):46. PubMed ID: 33066813
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients.
    Shi H; Fang X; Li Y; Zhang Y
    Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
    Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y
    Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma.
    Luo L; Zheng Y; Lin Z; Li X; Li X; Li M; Cui L; Luo H
    J Immunol Res; 2021; 2021():6647122. PubMed ID: 33928169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.
    Ji L; Tang Y; Pang X; Zhang Y
    Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers.
    Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS
    Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma.
    Wu X; Deng L; Tang D; Ying G; Yao X; Liu F; Liang G
    Tumour Biol; 2016 May; 37(5):6813-21. PubMed ID: 26662310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
    Bernhardt S; Bayerlová M; Vetter M; Wachter A; Mitra D; Hanf V; Lantzsch T; Uleer C; Peschel S; John J; Buchmann J; Weigert E; Bürrig KF; Thomssen C; Korf U; Beissbarth T; Wiemann S; Kantelhardt EJ
    Breast Cancer Res; 2017 Oct; 19(1):112. PubMed ID: 29020998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients.
    Liu L; Lan G; Peng L; Xie X; Peng F; Yu S; Wang Y; Tang X
    Ren Fail; 2016 Sep; 38(8):1199-205. PubMed ID: 27453328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile and prognostic value of SFN in human ovarian cancer.
    Hu Y; Zeng Q; Li C; Xie Y
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30926680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of NDUFA4L2 is associated with poor prognosis in patients with colorectal cancer.
    Lv Y; Nie SL; Zhou JM; Liu F; Hu YB; Jiang JR; Li N; Liu JS
    ANZ J Surg; 2017 Dec; 87(12):E251-E255. PubMed ID: 27226356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression.
    Cui X; Cui Y; Du T; Jiang X; Song C; Zhang S; Ma C; Liu Y; Ni Q; Gao Y; Wang G
    Can J Gastroenterol Hepatol; 2022; 2022():3758697. PubMed ID: 35211429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.
    Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H
    Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer proteome and metabolite changes linked to SHMT2.
    Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF
    PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis.
    Wei Z; Song J; Wang G; Cui X; Zheng J; Tang Y; Chen X; Li J; Cui L; Liu CY; Yu W
    Nat Commun; 2018 Oct; 9(1):4468. PubMed ID: 30367038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT.
    Huo FC; Xie M; Zhu ZM; Zheng JN; Pei DS
    Genomics; 2022 Jul; 114(4):110424. PubMed ID: 35798250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming.
    Liu Z; Fan M; Hou J; Pan S; Xu Y; Zhang H; Liu C; Hao X; Li X; Wang H
    Cell Death Dis; 2023 Feb; 14(2):144. PubMed ID: 36806313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors.
    Liu Y; Yin C; Deng MM; Wang Q; He XQ; Li MT; Li CP; Wu H
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9379-9392. PubMed ID: 31773687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation.
    Yang X; Wang Z; Li X; Liu B; Liu M; Liu L; Chen S; Ren M; Wang Y; Yu M; Wang B; Zou J; Zhu WG; Yin Y; Gu W; Luo J
    Cancer Res; 2018 Jan; 78(2):372-386. PubMed ID: 29180469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.